1. Introduction {#s0005}
===============

B cells act in the humoral immunity component of the adaptive immune response. B cells express B cell receptors (BCRs) on their cell membrane. BCRs allow B cells to bind to specific antigens, against which they will initiate antibody responses. B cells receive help from cognate helper T cells, and differentiate into plasma cells that secrete large amounts of antibodies [@bib1], [@bib2], [@bib3]. IL-4 is a cytokine that induces differentiation of naive helper T cells to Th2 cells. Upon activation by IL-4, Th2 cells produce additional IL-4 in a positive feedback loop. IL-4 is also secreted by NK-T cells, basophils, eosinophils and mast cells. IL-4 stimulates activated B-cell and T-cell proliferation, differentiation of B cells into plasma cells, B-cell class switching to IgE, and MHC class II production [@bib4], [@bib5], [@bib6].

The IL-4 pathway is a signaling cascade initiated by binding of IL-4 to its membrane receptor IL-4R. The activated IL-4R phosphorylates JAK1 and JAK3. JAK1 phosphorylates STAT6 which homodimerizes and enter the nucleus to regulate gene expression. JAK1 and JAK3 lead to activation of the Ras/MAPK pathway and NFκB, which cooperate with STAT6 for transcription [@bib7], [@bib8], [@bib9], [@bib10]. In the first systematic study which addressed the gene expression response of mouse spleen B cells (mSBC) to IL-4, costimulation with lipopolysaccharide (LPS) and anti-CD40 was used [@bib11]. Then, a few studies have reported the gene expression response of human B cells of diverse origin to IL-4 used as single stimulus [@bib12], [@bib13] or with anti-CD40 [@bib14]. Recently, a combined transcriptomic and proteomic study performed in mSBC costimulated with LPS and anti-CD40 established that regulation of protein expression by IL-4 occurs mainly at the transcriptional level [@bib15].

In the present paper, we intend to define the transcriptome response of mSBC to IL-4 as single stimulus, by the use of an experimental design which compares the sample cultured with IL-4 with two references ---the untreated sample and the sample cultured without IL-4. Such a design had already been used to define the response to IL-4 of human peripheral blood B cells (hPBBC) from healthy individuals and from chronic lymphocytic leukemia (CLL) B cells [@bib13]. Here, analysis has been optimized by calculating net changes induced by IL-4, which allowed a more stringent identification of the genes genuinely regulated by IL-4. Moreover, in order to shape the core response of B cells to IL-4 and the specific human and mouse responses, we have reanalyzed previous studies and compared their results. Finally, in order to identify the main functional axes activated by the transcriptional response of B cells to IL-4, we have performed for the first time gene set enrichment analysis (GSEA) using the Molecular Signatures database (MSigDB).

2. Material and methods {#s0010}
=======================

2.1. Isolation of mSBC and culture with IL-4 {#s0015}
--------------------------------------------

C57BL/6 N mice were bred at the animal facility of the University of Murcia under specific-pathogen-free conditions. All the procedures were performed according to the Directive 2010/63/EU on the protection of animals used for scientific purposes and approved by the Ethics Committee for Animal Experimentation of Hospital Clinico Universitario Virgen de la Arrixaca. Mice were killed by carbon dioxide asphyxiation and exanguination at 12 weeks of age. Spleens were excised and placed into a 100 µm cell strainer within an empty Petri dish. Following addition of 1 ml of PBS containing 2% fetal calf serum, 0.06% citrate, and 0.2 I.U. heparin per ml into the strainer, spleens were crushed using the plunger of a syringe. Cell suspensions were treated with ACK Lysing Buffer (Lonza, Basel, Switzerland), and negatively selected using the Pan B Cell Isolation Kit, mouse (Miltenyi Biotec, Bergisch Gladbach, Germany), following the manufacturer\'s instructions. B cells from 5 mice were cultured for 18 h in RPMI-1640 medium supplemented with 10% FCS (Cambrex, East Rutherford, NJ), 50 U/ml penicillin, 50 U/ml streptomycin, 2.5 μg/ml amphotericin B, and 2 mM [L]{.smallcaps}-glutamine with nothing and with adding 10 ng/ml of Pharmingen mouse recombinant IL-4 (BD Biosciences, San Jose, CA). These samples were designated *Ctrl* and *IL-4*, respectively, and that obtained before cell culture, sample *Pre*. Purity of the *Pre* samples was determined by labeling with monoclonal antibodies (moAb) CD3-FITC, CD19-PE-Cy5, and CD11b-PE and flow cytometry analysis in a BD FACScalibur flow cytometer, using the CellQuest software. Apoptosis of the *Ctrl* and *IL-4* samples was determined using the same procedure after labeling with annexin V-FITC and propidium iodide-PE.

2.2. RNA isolation {#s0020}
------------------

Total RNA was isolated using the miRNeasy Mini Kit (Qiagen, Hilden, Germany). RNA samples were quantitated on a NanoDrop 2000 (Thermo Fisher Scientific, Whaltham, MA). RNA quality was examined on an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) using the RNA 6000 Nano Kit. Only samples with RIN (RNA Integrity Number) \> 7 were further studied.

2.3. RNA labeling, microarray hybridization, and feature extraction {#s0025}
-------------------------------------------------------------------

RNA samples were labeled using Agilent Two Color Quick Amp Labeling and RNA Spike-In kits, according to the manufacturer\'s protocol. The RNA samples from mSBC (*Pre*, *Ctrl*, *IL-4*) were labeled with cyanine 5-CTP and used as tests. A pooled sample, previously described, was labeled with cyanine 3-CTP and used as reference [@bib16]. The labeled cRNAs were mixed together and hybridized onto Agilent Mouse GE 4 × 44 K v2 Microarray Kit targeting 39,430 Entrez Gene RNAs, using the Agilent Gene Expression Hybridization kit. After hybridization, the microarray slides were washed and scanned in an Agilent G2565CA DNA Microarray Scanner. Images were analyzed with the Agilent Feature Extraction software, which computes log ratios (test *vs* reference) following normalization correction by linear and Lowess methods. Datasets were deposited at the Gene Expression Omnibus (GEO) database under accession number (Acc. No.) [GSE73760](ncbi-geo:GSE73760){#ir0005}.

2.4. Microarray analysis {#s0030}
------------------------

Datasets were transformed into log~2~ ratios and reference conditions *Pre* and *Ctrl* were subtracted to condition *IL-4* to generate the *IL-4* -- *Pre* and *IL-4* -- *Ctrl* lists. The net change induced by IL-4 for each entity was the lowest, if positive ([Fig. 1](#f0005){ref-type="fig"}A and B), or the highest, if negative ([Fig. 1](#f0005){ref-type="fig"}D and E), of both subtractions, and the corresponding reference value, either *Pre* or *Ctrl*, will be called hereafter *Ref*. Entities taking values with opposite sign on both lists were excluded from further analysis ([Fig. 1](#f0005){ref-type="fig"}C and F). Comparison between *Ref* and *IL-4* values was performed using the Student *t*-test, and *p* values computed using the Benjamini-Hochberg FDR correction. Fold changes were calculated using the formula 2^(*IL−4\ --\ Ref*)^ for net positive changes or −2^−(*IL−4\ --\ Ref*)^ for net negative changes. Entities above 2-fold change (FC) and adjusted (adj.) *p* \< 0.05 were considered significantly regulated by IL-4. The same procedure has been applied for reanalysis of our previously published experiment performed on hPBBC and CLL treated with IL-4 for 18 h [@bib13] (GEO database Acc. No. [GSE55288](ncbi-geo:GSE55288){#ir0010}).Fig. 1Schematic of study design. Net changes in gene expression induced by IL-4 in mSBC and hPBBC were calculated following creation of two lists of genes by subtraction of both references, *Pre* and *Ctrl*, to *IL-4*, i.e., the *IL-4* -- *Pre* and *IL-4* -- *Ctrl* lists, expressed as log~2~ratios. For entities that took equal sign in both lists, net change was the smaller of the two values in absolute terms, positive (A and B) or negative (D and E). For entities that took opposite sign in both lists (C and F), net change could not be calculated and these entities were excluded. *Pre*, sample prior to culture; *Ctrl* and *IL-4*, samples cultured in parallel for 18 h with nothing and IL-4, respectively.Fig. 1

2.5. GSEA {#s0035}
---------

GSEA was performed to determine whether both conditions (*Ref* and *IL-4*) present significant differences for *a priori* defined set of genes comprised in the MSigDB (<http://software.broadinstitute.org/gsea/>).

2.6. Quantitative real-time polymerase chain reaction (qRTPCR) {#s0040}
--------------------------------------------------------------

RNA samples were subjected to reverse transcription with the iScript cDNA Synthesis Kit (Bio-Rad), following the manufacturer\'s instructions. QRTPCR was performed with the SYBR Premix Ex Taq (Takara Bio, Mountain View, CA) in an ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA). QuantiTect primer assays Mm_Casp6_2 (QT00494921), Mm_Cbr3_2 (QT02239174), Mm\_ Cdh1_1 (QT00121163), Mm_Cst7_1 (QT00114548), Mm_Epcam_2 (QT02304456), Mm_Grtp1_2 (QT01196237), Mm_Lifr_1 (QT00140980), Mm_Pmepa1_1 (QT00128779), Mm_Pole2_1 (QT00113386), Mm_Sdc1_2 (QT01751029), Mm_Sertad4_1 (QT00111482), Mm_Slc39a8_1 (QT00113092), Mm_Tbxas1_1 (QT01037106), Mm_Usp2_1 (QT00164906), Mm_Vdr_1 (QT00149345) and, as reference, Mm_Gapdh_3 (QT01658692) (Qiagen), were used. The relative expression values, expressed as fold change relative to the reference, were calculated using the formula 2^−ΔΔCt^ as described elsewhere [@bib13]. Comparisons between conditions *Pre*, *Ctrl* and *IL-4* were performed using 1-way analysis of variance (ANOVA) with Tukey\'s multiple comparison post test.

3. Results and discussion {#s0045}
=========================

3.1. Gene expression response of mSBC to IL-4 in vitro {#s0050}
------------------------------------------------------

The purified mSBC *Pre* samples included 94.1 ± 2.9% of CD3--CD19 + cells (mean ± S.D), 2.2 ± 2.3% of CD3 + CD19-- cells (T cells) and 1.4 ± 0.5% of CD3--CD19--CD11b+ cells (myeloid cells). Cell culture affected survival of mSBC negatively (40.1 ± 16.4% survival in *Ctrl*). IL-4 exerted a slight but significant positive effect (44.6 ± 17.2% survival in *IL-4*, Student\'s *t*-test *p* \< 0.05 for *Ctrl vs IL-4*). These data indicate that cell culture causes cell stress and should be treated as a confounder for analysis of gene expression regulation by IL-4 in mSBC. To minimize bias induced by cell culture, net changes induced by IL-4 were calculated, and entities for which *IL-4* -- *Pre* and *IL-4* -- *Ctrl* had opposite sign were excluded. A dataset which comprised the log~2~ratios of the *Ref* samples (either *Pre* or *Ctrl*, the one used to calculate net change for each entity) and the *IL-4* samples from 22,338 entities that passed the filter was generated, and then analyzed using the Student *t*-test and GSEA. Using Benjamini-Hochberg with *adj. p* \< 0.05, 284 probes, corresponding to 212 known genes, were positively regulated by IL-4 \> 2-fold ([Supplemental table 1](#s0065){ref-type="sec"}), and 335 probes, corresponding to 227 known genes, were negatively regulated by IL-4 \> 2-fold ([Supplemental table 2](#s0065){ref-type="sec"}). As will be mentioned later when referring to specific genes, qRTPCR validations confirmed significant differences between *IL-4* compared to *Pre* and *Ctrl* in 14 out of 15 genes ([Fig. 2](#f0010){ref-type="fig"}), with the only exception of Cbr3, which behaved by qRTPCR rather as a gene of the type exemplified in [Fig. 1](#f0005){ref-type="fig"}C.Fig. 2QRTPCR validations of transcriptome changes in mSBC in response to IL-4. QRTPCR analysis of 15 genes, 14 tested for upregulation (Casp6, Cbr3, Cdh1, Cst7, Epcam, Grtp1, Lifr, Pmepa1, Pole2, Sertad4, Slc39a8, Tbxas1, Usp2, and Vdr) and 1 for downregulation (Sdc1). All the genes validated microarray results except Cbr3. QRTPCR data are expressed as 2^--ΔΔCt^. *Pre*, sample prior to culture; *Ctrl* and *IL-4*, samples cultured in parallel for 18 h with nothing and IL-4, respectively. Bars indicate mean ± S.D., ANOVA with Tukey\'s multiple comparison post test, \*\* *p* \< 0.01, \*\*\**p* \< 0.001.Fig. 2

Our previous studies using hPBBC and CLL [@bib13], of similar design to the present study, were reanalyzed to calculate net changes. This approach resulted slightly more stringent with regards to the previously published lists of genes significantly regulated by IL-4, since they decreased from 123 genes to 95 genes (87 up and 8 down) in hPBBC and from 189 to 170 genes (130 up and 40 down) in CLL. In addition, recent studies by Xue et al. [@bib14] and Mokada-Gopal et al. [@bib15], performed on human tonsil B cells treated for 24 h with anti-CD40 ± IL-4 and mSBC treated for 96 h with LPS + anti-CD40 ± IL-4, respectively, were retrieved from the GEO database (acc. nos. [GSE71810](ncbi-geo:GSE71810){#ir0020} and [GSE84075](ncbi-geo:GSE84075){#ir0025}, respectively). The GEO2R tool, linked to the GEO website (<https://www.ncbi.nlm.nih.gov/geo/geo2r/>), was used to analyse the tonsil response, which consisted in 591 and 811 genes significantly upregulated and downregulated \> 2-fold with *adj. p* \< 0.05, respectively, according to the Student\'s *t*-test. Analysis of the mSBC study resulted in 469 and 344 genes. These figures are higher than those of our studies, likely partly due to false positives that could have been excluded if the baseline values had been measured and the net changes calculated. Nonetheless, these signatures, together with *Lu IL-4 Signaling Up* of the MSigDB, composed by 94 genes upregulated by IL-4 in hPBBC after 4 h of stimulation [@bib12], were compared with signatures from our mSBC and hPBBC studies in order to define mouse-specific, human-specific, or common gene expression responses of B cells to IL-4 ([Supplemental table 3](#s0065){ref-type="sec"}). Around 55% and \~66% of the genes upregulated and downregulated by IL-4, respectively, identified in mSBC in the present study were novel. The upregulated genes Sertad4, Lifr, Pmepa1, Epcam, Tbxas1, and the downregulated gene Sdc1, were validated by qPCR ([Fig. 2](#f0010){ref-type="fig"}).

The mouse-specific response to IL-4 also included \~28% upregulated genes and \~19% downregulated genes that overlapped with the signatures of the Mokada-Gopal\'s study but not with human signatures. Within this group, Usp2 activates Wnt signaling [@bib17]; Rab35 is a GTPase that regulates phosphoinositides and F-actin on endosomes [@bib18]; Grtp1 is a Rab-GAP with broad specificity [@bib19]; and Casp6 regulates B cell activation and differentiation into plasma cells by modifying cell cycle entry [@bib20]; among the downregulated genes, Gpr34 is a transmembrane G protein-coupled receptor (GPCR). The upregulated genes Usp2, Cst7 (cystatin), Grtp1, and Casp6 were validated by qRTPCR ([Fig. 2](#f0010){ref-type="fig"}). Other highly regulated genes within this group included St7, Klhdc2, Gadd45g, or Insm1, upregulated, and Anxa1, downregulated.

The remaining \~17% upregulated and \~15% downregulated genes have also been found in at least a human signature. This group includes 15 genes, 14 upregulated and 1 downregulated, that coincided in the present study in mSBC and our previous study in hPBBC. Among the upregulated genes, Cish and Socs1 are protein kinase inhibitors that take part in negative feedback loops to attenuate cytokine signaling [@bib21]; Nfil3 and Xbp1 are bZIP transcriptional regulators involved in Ig class switching and high-level Ig secretion by plasma cells [@bib22], [@bib23]; Vdr (vitamin D3 receptor) controls serum IgE levels [@bib24]; IL4i1, a [L]{.smallcaps}-phenylalanine oxidase, controls BCR-dependent activation [@bib25]; Dock10, a Rac1 and Cdc42 guanine-nucleotide exchange factor (GEF), is involved in B cell development [@bib16]; Auh, an RNA-binding hydratase, is involved in mitochondrial protein synthesis [@bib26]; the Vmp1 gene hosts miR-21 [@bib27]; and Il4r takes part in a positive feedback loop to amplify IL-4 signaling [@bib4]. Vdr, Cdh1 (E-cadherin), and Slc39a8 were validated by qRTPCR in mSBC ([Fig. 2](#f0010){ref-type="fig"}).

An hPBBC response to IL-4, not shared by mSBC, was also detected. Among the upregulated genes, CCL17 plays a role in class switch recombination [@bib22]; GCSAM induces Syk phosphorylation and negatively regulates cell motility through Rho activation [@bib28], [@bib29]; and IL2RA drives differentiation of B cells towards plasma cells [@bib30]. Other highly upregulated genes of this group included RASL10A, MTCL1, SLC37A3, HS3ST1, MELTF, ZBTB8A, CLEC4A, HOMER2, GNG8, QSOX1, or PALLD.

Finally, to assess which responses are specific to B cells, the responses of mSBC and hPPBC were compared to those of mouse splenic T cells (mSTC) and human cord blood T cells (UCTC), reported by Chen *et al.* [@bib31] and Kanduri et al. [@bib32], respectively ([Supplemental table 3](#s0065){ref-type="sec"}). In these studies, CD4 cells were treated with anti-CD3 + anti-CD28 ± IL-4, for 48 h and 72 h, respectively. The mSTC study identified 31 upregulated and 90 downregulated genes, of which only 8 (Cish, Nfil3, Il4i1, Casp6, Lilrb4, Hipk2, Gp49a, and Il4ra) and 4 (Ifng, Ltb, Trim30b, Ifi203) overlapped with our present mSBC study, respectively. The UCTC study included two references, allowing calculate net changes (GEO acc. no. [GSE71575](ncbi-geo:GSE71575){#ir0035}), and analysis using GEO2R resulted in 67 and 25 genes, of which only 7 upregulated (GFI1, IGSF3, SOCS1, NFIL3, LRRC32, SPINT2, and ITPRIPL2) overlapped with hPBBC. Therefore, most of the IL-4 response of B cells is specific.

3.2. GSEA {#s0055}
---------

To gain insights into the functional meaning of gene expression changes induced by IL-4, we performed GSEA in mSBC and hPBBC. We first summarize significant pathways found both in mSBC and hPBBC ([Fig. 3](#f0015){ref-type="fig"}). The Chemical and Genetic Perturbations collection of the MSigDB comprises numerous pairs of up and down signatures. We judge that significance of a signature is higher when the up and down gene sets are both significant, with opposite sign, with respect to conditions *Ref* and *IL-4*, or vice versa. The most significant and recurrent pairs were found for the upregulated and downregulated targets of Myc, associated to *IL-4* and *Ref*, respectively, which strongly suggests that IL-4 potentiates Myc function. In addition, GSEA using the Canonical Pathways and Cellular Components collections revealed changes induced by IL-4 in the transcriptional machinery itself (RNA polymerase, spliceosome), stimulation of the cell cycle machinery (DNA replication, mitotic spindle), mitochondrial activity (oxidative phosphorylation, mitochondrial matrix, mitochondrial envelope), the ribosome, and the proteasome (antigen presentation, endosomes), positive regulation of Wnt signaling, and negative regulation of GPCR signaling.Fig. 3Common pathways and cellular components regulated by IL-4 in mSBC and mPBBC according to GSEA. Histograms depict results of comparisons *IL-4 vs Ref* in mSBC. The headers of some histograms are shortened designations for the following gene sets: *GO: RNA polymerase complex*, *GO: Mitochondrial protein complex*, *Reactome: Cross-presentation of soluble exogenous antigens -- Endosomes*, *GO: Organellar ribosome*, *Reactome: Regulation of mitotic cell cycle*, *Reactome: Signaling by Wnt*, and *Reactome: Signaling by GPCR*. ES, enrichment score; FDR, false discovery rate; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; NES, normalized enrichment score.Fig. 3

Interesting relationships specifically found in mSBC included the upregulated and downregulated targets of the lysine demethylase Kdm1a, associated to *Ref* and *IL-4*, respectively ([Fig. 4](#f0020){ref-type="fig"}A), suggesting that this component of histone deacetylase complexes is inhibited by IL-4 in mSBC. In addition, Nod signaling, Rho signaling, and filamentous actin were downregulated by IL-4 in mSBC. On the other hand, the upregulated and downregulated targets of Smarca2 were associated to *Ref* and *IL-4*, respectively, specifically in mPBBC ([Fig. 4](#f0020){ref-type="fig"}B), suggesting that this component of the SWI/SNF chromatin remodeling complex is activated by IL-4 in hPBBC. Consistent with this finding, the nucleosome was downregulated by IL-4 in hPBBC.Fig. 4Specific pathways and cellular components regulated by IL-4 in mSBC (A) and mPBBC (B) according to GSEA. Histograms depict results of comparison *IL-4 vs Ref*. The headers of some histograms are shortened designations for the following gene sets: *Reactome: Nod1/2 signaling pathway*, *Reactome: Signaling by Rho GTPases*, and *GO: Nuclear nucleosome*. ES, enrichment score; FDR, false discovery rate; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; NES, normalized enrichment score.Fig. 4

In summary, the present study dissected and compared the transcriptomic responses of mouse and human B cells to IL-4. Our study is unique in that baseline values were measured, which increased the ability to filter out false positives. In addition, we used GSEA and show for the first time the major axes of the transcriptomic response of B cells to IL-4, which have broad common features in mouse and human but also specific features, such as the choice of pathways that regulate access to chromatin. We conclude that the human and mouse transcriptomic responses of B cells to IL-4 significantly overlap, but mouse and human specific responses are also significant, in contrast to the small overlap between B and T cell responses. IL-4 activated both in mouse and human B cells central processes such as transcription and translation, respiratory chain, cell cycle, survival, and specific pathways such as Wnt signaling, but diverged in others such as histone demethylation, Nod, and Rho signaling. Discrimination between responses of murine and human B cells is important in the interpretation of studies on the function of IL-4, and has implications for its possible therapeutic application for the treatment of allergic diseases, helminth infections and B cell malignancies.
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